- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Forever Chemicals (PFAS)
Insights 28 results
Newsletter
August 1, 2022
Focus on Forever – August 1, 2022
Newsletter
June 30, 2022
Focus on Forever – June 30, 2022
Newsletter
June 13, 2022
Focus on Forever – June 13, 2022
Newsletter
May 20, 2022
Focus on Forever – May 20, 2022
Newsletter
May 3, 2022
Focus on Forever – May 3, 2022
Newsletter
April 18, 2022
Focus on Forever – April 18, 2022
Newsletter
March 29, 2022
Focus on Forever – March 29, 2022
Newsletter
March 10, 2022
Focus on Forever – March 10, 2022
Newsletter
February 23, 2022
Focus on Forever– February 22, 2022
Newsletter
February 9, 2022
Focus on Forever– February 9, 2022
Client Alert
January 26, 2022
Spotlight on PFAS and Other Substances in Cosmetics Likely to Grow in 2022
Newsletter
January 25, 2022
Focus on Forever– January 25, 2022